NCT05027906 - Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 18, 2022

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions

Prevention of Rejection in Kidney Transplant

Interventions

DRUG

AT-1501

Investigative Arm

Trial Locations (9)

RECRUITING

Royal Prince Alfred Hospital, Camperdown

RECRUITING

University of Cincinnati, Cincinnati

RECRUITING

Royal Adelaide Hospital, Adelaide

RECRUITING

Fundação Oswaldo Ramos - Hospital do Rim, São Paulo

RECRUITING

Providence Health Care - St. Paul's Hospital, Vancouver

RECRUITING

Vancouver General Hospital, Vancouver

RECRUITING

McGill University Health Care Centre, Montreal

RECRUITING

Liverpool University Hospitals NHS Foundation Trust - Royal Liverpool University Hospital, Liverpool

RECRUITING

Oxford University Hospitals NHS Foundation Trust - John Radcliffe Hospital, Oxford